Frank Ruschitzka
Frank Ruschitzka, MD is an expert in Cardiology at University Hospital of Zurich (Switzerland). As of September 2026, ScienceLeadR ranks Frank Ruschitzka in the top 1% of experts worldwide for Heart Failure and Cardiomyopathies. Frank Ruschitzka has authored 813 publications, the most recent in 2026, and is an investigator in 39 clinical trials, 2 of them ongoing. SLR score: 2,904 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Public Health - Biochemistry - Internal Medicine
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1996 - 2026
Number : 813
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Physical activity and exercise training in patients with HFrEF - Authors' reply. PMID 42753760 — exercise, heart failure, systolic | Lancet Top journal | 2026 | 0 |
| Timing of PCI in Patients Undergoing Transcatheter Aortic-Valve Implantation. PMID 42670987 — constriction, pathologic, aortic valve stenosis, coronary artery disease, arteries, aortic valve, transcatheter aortic valve replacement, random allocation | N Engl J Med Top journal | 2026 | 3 |
| CMR Reveals the Influence of Trigger and Classification on the Myocardial Tissue Response in Takotsubo Syndrome. PMID 42381632 — heart, classification, magnetic resonance imaging, diagnostic imaging, prevalence, tissues, edema, takotsubo cardiomyopathy | Circ Cardiovasc Imaging | 2026 | 0 |
| Congestion, but not low cardiac output, is independently associated with acute kidney injury following contrast agent exposure. PMID 42375846 — contrast media, cardiac output, low, kidney, cardiac output, acute kidney injury | Front Cardiovasc Med | 2026 | 1 |
| Killip class at presentation and immediate versus staged multivessel PCI in patients with STEMI. PMID 42362625 — myocardial infarction, st elevation myocardial infarction, therapeutics | Sci Rep | 2026 | 0 |
Clinical Studies 39
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 33
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Dose Escalation for SBRT of Recurrent VT Ventricular Tachyarrhythmia a Single Center Phase II Clinical Trial NCT05594368 — radiotherapy, tachycardia, ventricular, arrhythmias, cardiac, multiple chronic conditions, tachycardia, therapeutics, catheter ablation, catheters | Phase 1 | Recruiting | 2022 |
| Sacubitril Valsartan in Left Ventricular Assist Device Recipients NCT04103554 — pilot projects, pilots, valsartan, heart failure, pharmaceutical preparations, heart, drug combinations | Phase 4 | Active not recruiting | 2021 |
LeadR Networks
Main global connection map